Table of Contents Table of Contents
Previous Page  39 / 60 Next Page
Information
Show Menu
Previous Page 39 / 60 Next Page
Page Background

37

NCCN Guidelines for Patients

®

:

Breast Cancer – Metastatic (STAGE IV), Version 2.2017

Review

†

†

The treatment approach for metastatic breast

cancer is to use a whole-body treatment until

it doesn’t work then use another. This allows

long-term cancer control for many women.

†

†

Clinical trials give people access to new tests

and treatments that they otherwise can’t

receive. If proven to work well, they may be

approved in time by the FDA.

†

†

Endocrine therapy works well for hormone

receptor–positive cancers. These cancers may

also be treated with targeted therapy. Which

treatment you will receive is based on your prior

treatment and menopausal status.

†

†

Chemotherapy and targeted therapy are

used to treat hormone receptor–negative

cancers. These treatments are also used to

treat hormone receptor–positive cancers that

haven’t improved on 3 back-to-back endocrine

therapies. Which treatment you will receive

depends on your prior treatment and the HER2

status of the cancer.

†

†

Testing during treatment should occur on a

regular basis to check if treatment is working

and not causing serious side effects.

3

Treatment guide

Review

Side effects from treatment can be

difficult to manage. I sometimes

wish that treatment wasn’t such

a bully… except when it comes to

fighting the cancer.

–Lynn

Guide 8. Testing schedule

Before new

treatment

During

endocrine therapy

During

chemotherapy

Signs of cancer

progression

Symptoms

Yes

Every 1–3 months

Before each cycle Yes

Physical exam

Yes

Every 1–3 months

Before each cycle Yes

Weight

Yes

Every 1–3 months

Before each cycle Yes

Performance status Yes

Every 1–3 months

Before each cycle Yes

CBC

Yes

Every 1–3 months

Before each cycle Yes

Liver function tests

Yes

Every 1–3 months

Before each cycle Yes

CT scan

Yes

Every 2–6 months

Every 2–4 cycles

Yes

Bone scan

Yes

Every 4–6 months

Every 4 cycles

Yes

PET/CT scan

It’s an option It’s an option

It’s an option

It’s an option

Tumor markers

It’s an option It’s an option

It’s an option

It’s an option